irradiation. Indeed membrane-active agents such as local anaesthetics, analgesics and tranquillizers have been shown to enhance radiation effects on cells . A commonly used tranquillizer, chlorpromazine HCI (CPZ), has shown great promise in increasing the radiation sensitivity of hypoxic bacterial and mammalian cells in vitro as well as mouse solid tumours in vivo (George et al., 1980; Shenoy & Singh, 1980) . This drug also showed preferential cytotoxicity to hypoxic bacterial cells (Shenoy & Singh, 1978) and a mouse fibrosarcoma in vivo (George et al., 1980) .
Since the plasma membrane is also the main organelle involved in heat-killing of cells (Har-Kedar & Bleehen, 1976) CPZ, by virtue of its membrane activity, might potentiate the therapeutic effect of hyperthermia. We have therefore investigated the effect of CPZ on the thermal sensitivity of two murine solid tumours in vivo.
The tumours used in the present study were a sarcoma 180 (Si80) and a fibrosarcoma described elsewhere (Shenoy & Singh, 1980 : George et al., 1980 . Both were serially transplantable and grown s.c. on the ventral wall of the thorax of 8-week-old female Swiss mice weighing Accepte(d 19 October 1981 19-25 g. When the tumours reached a mean diameter of 7 + 1 or 8 + 1 mm for 8180 and the fibrosarcoma respectively, they were randomly distributed between 4 groups comprising control animals and those receiving CPZ or heat or both. Pharmaceutical-grade CPZ (May & Baker Ltd, India) was dissolved in sterile normal saline at a concentration of 0-25 mg/ml. To ensure maximum drug level at the site, CPZ at a dose of 5 mg/kg body wt was given as a single injection with a 27-gauge needle in a volume of 0-38-0 5 ml solution directly to the centre of the tumours in unanaesthetized animals 5 min before heating. The control animals received an equal volume of normal saline. Usually no haemorrhage or necrosis of the tumour was observed after such treatments. If any such effects were noticed, the animal was discarded.
Experiments using radioactive CPZ (35S) revealed that with this mode of injection the drug level in the tumour remained constant for more than 60 min. All heat treatments of tumours were therefore given for 1 h, excluding the time taken by the tumour to attain the maximum temperature. Tumours were heated by laying the animals horizontally in specially designed jigs with holes, through which the tumours could protrude downwards to be fully immersed in the waterbath. Animals were gently held in position by adhesive tapes. Heating the tumours was carried out in a thermostatically controlled ( + 01-C) circulating waterbath (Gallenkam), England). Cool air was blown across the water bath to reduce the humidity of the inspired air as well as to prevent the body temperature from rising. Intratumour temperatures were measured separately in a different set of animals, by needle thermocouple probe in association with a direct-reading electric thermometer (Omega Engineering, Inc., U.S.A.). The probe was inserted s.c. above the water level and passed down to the centre of the tumour to minimize errors in temperature reading due to heat conduction along the probe. Within 5-10 min both the tuniours attained a temperature 0 5 + 0 2°C less than that of the waterbath, and maintained it throughout the duration of the heating. Although the temperature across a tumour may vary considerably, the intratumour temperature referred to in our report is the central tumour temperature. Rectal tempera- lethal. In the present series of experiments detailed toxicity studies were not carried out, but a non-lethal dose of the drug (5 mg/kg) was maintained. Fig. 1 shows the growth characteristics of S180 after CPZ and heat treatments. Neither treatment with CPZ alone nor heating at 40 5°C influenced tumour growth. However, marginal delay in tumour growth was indicated when these treatments were combined. Heat alone at 41-5 or 42-50C completely regressed this tumour. The mean periods for tumour disappearance at these temperatures were 1 6 2 + 0 6 and 9 8 + 0 7 days respectively. Whereas only a marginal effect could be seen on the combined treatment with drug plus heat at 41 5°C (growth delay = 15 8 + 0*7 days), hardly any drug effect could be noticed over the heat effect at 42-50C. These results thus indicate the ineffectiveness of CPZ in S180 at elevated temperatures.
For the fibrosarcoma, the growth rate and the average time taken to reach a diameter of II mm after CPZ and heat 1i4+0-6 9-8+0-9 5-5+1 0 -r is 8+1 mm. Number of was 7-11. treatments are shown in Fig. 2 and the Table respectively. Here again, neither the drug alone nor heat alone at 41°C, or a combination thereof, produced any significant delay. In contrast, administration of CPZ before heating the tumours to 42°C caused substantial delay in the growth compared to tumours heated without the drug (Fig. 2 and Table) . No cures were detected in these experiments, however.
The response of these tumours to heat alone is consistent with the general findings reported earlier, that temperatures below 41-50C have no pronounced effect (Crile, 1962; Overgard & Overgard, 1972; Stewart & Denekamp, 1978) . Growth of some tumours has, however, been controlled by local heat treatments at higher temperatures (Crile, 1963; Overgard & Overgard, 1972) . In the present study, heating of tumours to 41b50C for 1 h caused complete disappearance of S180, indicating its high heat sensitivity. On the other hand, the fibrosarcoma showed less heat sensitivity, since heat, even at 42°C, produced little growth delay. These tumours also differ in their response to the combined action of CPZ and hyperthermia, as discussed above. Since the fibrosarcoma was initially produced and maintained in an inbred strain of Swiss mice it is non-immunogenic (Sahasrabudhe et al., 1977) . On the other hand, S180 is believed to be immunogenic (S. Sato, NCRI, Tokyo, personal communication). Whether their differential response to heat and CPZ can be attributed to this factor needs further investigation. However, it is known that the fluidity of a cell membrane plays a major role in its sensitivity to heat (Yatvin, 1977) . Since CPZ and other membraneactive drugs fluidize membrane lipids (Seeman, 1972; Feinstein et al., 1975; Papahadjopoulos et al., 1975; Singer, 1977) an interaction between the effects of such drugs and heat is expected. The different responses of S180 and the fibrosarcoma to the combined treatment with CPZ and heat may therefore also be attributable to differences in the membrane fluidity of these two tumour lines.
With a view to ascertaining this possibility, fluorescence-polarization studies were carried out using 1,6-diphenyl-1,3,5-hexatriene (DPH) as a hydrophobic fluorescent probe. Single-cell suspensions of the fibrosarcoma and S180 were prepared by trypsinization. Cells suspended in phosphate-buffered saline (pH 7.2) at a concentration of 107 cells/ml were equilibrated with 1OtUM DPH for 1 h at room temperature in a water-bath shaker.
The polarization of fluorescent light (Amax 430 nm) was measured with the help of an Amnico Bowman spectrophotofluorimeter equipped with Glan polarizers. The polarization factor P was calculated as P'IEE-IEB IEE + IEB where IEE and IEB are the intensities of fluorescent light with the excitation polarizer always set at the E position, and the emission polarizer set at E and B positions respectively. Suitable corrections to IEB were made to account for scattering from cells as well as for relative transmission of the emission monochromator. The polarization factor for fibrosarcoma (P= 0-202 + 0.005) was significantly different from that for S180 (P=0.180+0.002). As P is a direct measure of the fluidity of the hydrophobic region of the membrane, these results indicate that the S180 membrane is relatively more fluid than that of fibrosarcoma, which may account for its greater heat sensitivity. Although no such comparative measurements on tumours with different heat or drug sensitivities have been made, several investigations into P values of normal and transformed cells have been reported, with varying results (Fuchs et al., 1975; Edward et al., 1976; Hatten et al., 1978; Monti et al., 1979) . Different P values have been reported for cells even of the same origin but with different morphologies. A gradient across the membrane for P has also been observed (Schroeder, 1980) . In view of these facts, our present interpretation of the relationship between hyperthermic response and P values of two tumour lines may appear an over-simplication. They nevertheless open a possible new dimension to our understanding of the hyperthermic response of cells.
The present indicator that CPZ may be a hypoxic cell radiosensitizer, gives some promise for its use in a combined modality for cancer treatment.
